<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bas S</dc:creator>
  <dc:creator>Perneger TV</dc:creator>
  <dc:creator>Mikhnevitch E</dc:creator>
  <dc:creator>Seitz M</dc:creator>
  <dc:creator>Tiercy JM</dc:creator>
  <dc:creator>Roux-Lombard P</dc:creator>
  <dc:creator>Guerne PA</dc:creator>
  <dc:date>2000</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVES
To evaluate and to compare the association of two types of autoantibodies-rheumatoid factors (RF) and anti-filaggrin antibodies (AFA)-with clinical severity and joint damage progression in rheumatoid arthritis (RA) patients.


METHODS
In a cross-sectional study, we determined RF and AFA titres in 199 RA patients and 65 controls. Erosions apparent on X-rays were quantified using the Larsen score in 143 patients, and the distribution of these scores was studied according to disease duration in patients who were positive and negative for RF and AFA.


RESULTS
RF were detected in 72% and AFA in 47% of RA patients. AFA were highly specific for RA (100%). RF positivity was correlated with the presence of subcutaneous nodules, sicca syndrome and the severity of erosions for a given disease duration. AFA positivity was correlated only with the presence of the HLA-DRB1 shared epitope.


CONCLUSIONS
Since no significant correlation was observed between joint damage progression and AFA positivity, the determination of AFA does not appear to be useful in assessing the prognosis of RA. However, AFA, which appear early in RA, could be helpful for the diagnosis of RA in patients who do not fulfil four American College of Rheumatology criteria.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/26235</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/rheumatology/39.10.1082</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/11035127</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Rheumatology (Oxford, England). - 2000</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Aged, 80 and over</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Arthritis, Rheumatoid</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Arthrography</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Autoantibodies</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Cross-Sectional Studies</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Intermediate Filament Proteins</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Rheumatoid Factor</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Sensitivity and Specificity</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Time Factors</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
